Keywords: Multi-Contrast, Preclinical, Multinuclear
Motivation: Multinuclear contrast agents (CAs) may provide improved sensitivity and specificity for the detection/quantification of biomolecular processes.
Goal(s): To develop a multinuclear 1H and 19F agent that shortens the T1 relaxation times for both the 1H and 19F signals only when hydrogen peroxide (H2O2) is present.
Approach: Developed the CA: Fe(II)-F2H4qp4 -- an iron(II) complex with a fluorinated quinol-containing macrocyclic ligand. This T1-shortening CA is designed to activate only in the presence of H2O2.
Results: Initial phantom tests with an 1H/19F frequency-selectable Inversion Recovery Look Locker sequence
demonstrate a dual capability to quantify changes of both 1H and 19F signal T1 values.
Impact: The multinuclear Fe(II)-F2H4qp4 agent's ability to quantify changes of both 1H and 19F signal T1 values in an H2O2 environment improves the sensitivity and specificity to superoxide-related pathologies and may allow expanding to other biomarkers.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords